Position in AMGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$7,761,317
+$291,542 QoQ
Shares Held
21,433
+1.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#642
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TOCQUEVILLE ASSET MANAGEMENT L.P. holds $293,455,653 across 12 Drug Manufacturers - General names. AMGN ranks #8 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
336,097 | $84,575,449 | |
| 2 | JNJ |
Johnson & Johnson
|
258,233 | $65,583,435 | |
| 3 | MRK |
Merck & Co., Inc.
|
447,832 | $57,546,412 | |
| 4 | LLY |
ELI LILLY & Co
|
24,659 | $29,576,746 | |
| 5 | NVS |
Novartis AG
|
79,360 | $12,437,299 | |
| 6 | PFE |
Pfizer Inc
|
465,004 | $11,197,296 | |
| 7 | SNY |
Sanofi
|
195,567 | $8,342,888 | |
| 8 | AMGN |
Amgen Inc
This page
|
21,433 | $7,761,317 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,761,317 | 21,433 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $7,469,775 | 21,230 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $7,174,635 | 21,920 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,030,614 | 21,370 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,163,281 | 22,074 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $6,480,240 | 20,800 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $5,249,810 | 20,142 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $6,517,341 | 20,227 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $6,694,866 | 21,427 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $6,182,254 | 21,744 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $6,279,412 | 21,802 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $6,141,434 | 22,851 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $5,185,499 | 23,356 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,711,827 | 23,627 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $6,241,902 | 23,766 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $5,446,114 | 24,162 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $6,851,814 | 28,162 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $7,001,898 | 28,955 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,390,947 | 28,408 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,378,011 | 29,993 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,336,875 | 30,100 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,463,055 | 29,995 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,037,621 | 30,609 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,052,042 | 31,681 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $7,663,798 | 32,493 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $7,089,670 | 34,971 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||